Atle Fund Management Ab Portfolio Stock Holdings
Atle Fund Management Ab disclosed 39 stock positions valued at approximately $371.7 million in its latest SEC 13F filing. The largest holdings include ELI LILLY & CO, MERCK & CO. INC, and JOHNSON & JOHNSON. The filing reflects positions held as of June 30, 2026 and was filed on July 24, 2026.
- Report Period
- June 30, 2026
- No. of Stocks
- 39
- Portfolio Value
- $371.7M
Holdings by Sector
Atle Fund Management Ab Portfolio Holdings in Q2 2026
36 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ELI LILLY & CO | LLY | Healthcare | 9.62% | 29,821 | -9,901 | -24.93% | $35,768,202 |
| MERCK & CO. INC | MRK | Healthcare | 6.55% | 189,357 | +155,504 | +459.35% | $24,332,374 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 5.84% | 85,425 | -6,952 | -7.53% | $21,695,387 |
| ABBVIE INC | ABBV | Healthcare | 4.35% | 64,325 | -43,856 | -40.54% | $16,186,743 |
| CVS HEALTH CORP | CVS | Healthcare | 4.07% | 146,102 | +122,329 | +514.57% | $15,114,251 |
| THERMO FISHER SCIENTIFIC CORP | TMO | Healthcare | 3.76% | 27,859 | +4,873 | +21.20% | $13,967,388 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 3.68% | 73,077 | -544,168 | -88.16% | $13,685,860 |
| BIOGEN INC | BIIB | Healthcare | 3.65% | 62,781 | +62,781 | +100.00% | $13,564,462 |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 3.31% | 72,898 | -16,787 | -18.72% | $12,285,864 |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 3.17% | 100,807 | -94,961 | -48.51% | $11,801,475 |
| ALKERMES PLC | G01767105 | Other | 3.01% | 213,329 | -29,144 | -12.02% | $11,177,372 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 2.93% | 137,131 | +109,258 | +391.99% | $10,873,116 |
| BEONE MEDICINES LTD-ADR | BGNE | Healthcare | 2.70% | 35,180 | -6,537 | -15.67% | $10,025,244 |
| INTUITIVE SURGICAL INC | ISRG | Healthcare | 2.64% | 24,656 | -46,195 | -65.20% | $9,805,198 |
| STRYKER CORPORATION | SYK | Healthcare | 2.57% | 30,283 | +3,448 | +12.85% | $9,534,299 |
| VERTEX PHARMACEUTICALS INC | VRTX | Healthcare | 2.56% | 19,131 | -3,853 | -16.76% | $9,502,941 |
| EDWARDS LIFESCIENCES CORP | EW | Healthcare | 2.51% | 103,230 | -3,288 | -3.09% | $9,338,185 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 2.50% | 124,707 | +13,344 | +11.98% | $9,288,177 |
| KRYSTAL BIOTECH, INC | KRYS | Healthcare | 2.40% | 24,019 | -13,560 | -36.08% | $8,927,141 |
| CENCORA INC | COR | Healthcare | 2.37% | 31,126 | +7,656 | +32.62% | $8,808,035 |
| NEWAMSTERDAM PHARMA CO NV | NAMSW | Other | 2.27% | 248,848 | +154,052 | +162.51% | $8,433,458 |
| ABIVAX SA | ABVX | Healthcare | 2.09% | 58,170 | +26,580 | +84.14% | $7,751,734 |
| INCYTE CORP | INCY | Healthcare | 1.74% | 56,953 | +6,157 | +12.12% | $6,456,192 |
| IRHYTHM TECHNOLOGIES INC | IRTC | Healthcare | 1.73% | 54,102 | +31,780 | +142.37% | $6,435,432 |
| BOSTON SCIENTIFC | BSX | Healthcare | 1.68% | 146,381 | +105,949 | +262.04% | $6,247,541 |
| INSMED INC | INSM | Healthcare | 1.67% | 58,378 | -39,060 | -40.09% | $6,224,262 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 1.67% | 198,557 | +168,642 | +563.74% | $6,206,891 |
| GILEAD SCIENCES INC | GILD | Healthcare | 1.57% | 46,142 | -1,825 | -3.80% | $5,829,580 |
| CARDINAL HEALTH INC | CAH | Healthcare | 1.51% | 23,630 | -85,052 | -78.26% | $5,613,542 |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 1.36% | 57,030 | -5,705 | -9.09% | $5,063,123 |
| DEXCOM INC | DXCM | Healthcare | 1.30% | 71,846 | -512,486 | -87.70% | $4,838,828 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 0.95% | 94,478 | +63,345 | +203.47% | $3,521,195 |
| CELCUITY INC | CELC | Healthcare | 0.94% | 33,313 | -107,983 | -76.42% | $3,485,206 |
| DISC MEDICINE INC | IRON | Healthcare | 0.86% | 43,682 | -63,573 | -59.27% | $3,194,901 |
| PYXIS ONCOLOGY INC | PYXS | Healthcare | 0.78% | 966,459 | +769,423 | +390.50% | $2,909,041 |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 0.62% | 1,048,593 | +1,006,762 | +2406.74% | $2,296,418 |